Reports cash position of $2.31B as of March 31.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HZNP:
- Horizon Pharma put volume heavy and directionally bearish
- TD Cowen merger specialist to hold an analyst/industry conference call
- Viridian Therapeutics initiated with an Overweight at Wells Fargo
- Horizon Therapeutics announces FDA approval of Tepezza indication update
- Horizon announces results from Tepezza trial in patients with CAS, TED